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DNA is the repository of the genetic information in each living organism and its integrity and
faithful transmission has to be ensured across generations for our own survival. Despite DNA has
evolved as a more stable molecule than its ancient predecessor RNA, it is not able to guarantee
life-long stability. Random changes occurring at the level of DNA represent the main source of
genetic variability and the raw material on which Darwinian evolution acts.
In all organisms, cells experience massive amounts of damaging events each day. For
instance, DNA injuries occur with a frequency of 104–106 in a single human cell per day.
DNA lesions can have deleterious effects, as they interfere with basic cellular transactions,
such as genome replication and transcription. If DNA injuries are mis-repaired or unrepaired,
they may ultimately result in mutations or wider-scale genome aberrations that threaten
cell homeostasis. As a proof of the fact, genome instability is a hallmark of tumorigenesis
and tumor progression (Hanahan and Weinberg, 2011). On the other hand, DNA injuries
increase during time as result of the imbalance between generation and scavenging of by-
products deriving from cellular metabolism. Therefore, DNA damage promotes cellular senescence
or cell death (Malaquin et al.), thus contributing to aging or to onset of aging-related
disorders.
DNA damage can attack most parts of the DNA structure, ranging from minor and major
chemical modifications, to single-strand breaks (SSBs) and gaps, to full double-strand breaks
(DSBs; Brown and Baltimore, 2000). DNA lesions can arise as consequence of physiological
processes like DNA replication (Jossen and Bermejo; Ouyang et al.) or can be caused by the
exposure to environmental toxins. For example, the mis-incorporation of nucleotides during
DNA replication contributes to the spontaneous mutation rate in an organism. While, canonical
DNA polymerases are proofreading enzymes able to recognize and correct many of these
errors, some mutations can escape this process. Other endogenously-arising DNA alterations
lead to loss or modification of DNA bases (Lindahl, 1993). By-products of physiological cellular
metabolism, such as reactive oxygen species (ROS) derived from oxidative respiration (Markkanen
et al.), side-products of lipid peroxidation, or aldehyde metabolism (Finkel and Holbrook, 2000),
constitute a permanent enemy to DNA integrity as they ultimately lead to DNA oxidation and
breaks.
DNA damage is otherwise produced environmentally by chemical and physical sources. The
most pervasive DNA-damaging agents are ultraviolet (UV) light derived from sunlight and ionizing
radiation (IR). Despite the ozone layer absorbing the most dangerous part of the ultraviolet
spectrum (UV-C), the other two types of UV radiation, UV-A and UV-B, are able to penetrate
Earth’s atmosphere and reach the planet’s surface, thus being of greatest concern to humans.
Exposure to UV radiation induces formation of cyclobutane pyrimidine dimers (CPDs) and 6–4
Porro Editorial: The Multifaceted World of the DNA Damage Response
photoproducts. Such lesions distort DNA’s backbone, introducing
bends or kinks that can represent a serious impediment
for transcription and replication processes. In addition, IR
originating from the decay of naturally occurring radioactive
compounds or from medical treatment employing X-rays and/or
radiotherapy, also generates various forms of DNA damage.
Finally, certain types of chemicals can also cause a variety
of DNA lesions. DNA-damaging chemicals are mainly used
in chemotherapy, but can be present in contaminated foods,
such as heterocyclic amines produced in over-cooked meat
or aflatoxins detected in contaminated peanuts. Remarkably,
tobacco products derived by cigarette smoking are the most
prevalent environmental DNA-damaging chemical agents as they
cause a wide variety of DNA adducts and oxidation, which can
ultimately trigger cancer of the lung and adjacent tissues.
In order to preserve the integrity of the genome, cells have
evolved an integrated signaling network of damage detection and
repair: the DNA damage response (DDR; Lindahl and Barnes,
2000). The DDR senses different types of genotoxic lesions and
mounts coordinate and multi-faceted responses, that ultimately
fix DNA lesions in a timely manner and prevent their conversion
into permanent genomemutations (Hoeijmakers, 2001; Harrison
and Haber, 2006; Harper and Elledge, 2007; Jackson and Bartek,
2009). Moreover, the DDR also activate checkpoints to arrest or
delay cell cycle progression or, if repair fails, trigger apoptosis.
Cell cycle checkpoints are a genome surveillance mechanisms
monitoring and controlling the timing and order of cell cycle
events (Ferretti et al.; Jossen and Bermejo). Indeed, the DDR
signaling pathways modulate the activity of cell cycle regulators
and DNA repair enzymes, thus ensuring tight coordination of
DNA repair with cell cycle progression. At molecular level, DDR
is organized into an elaborate network of interacting pathways,
the constituents of which can be grouped into three major classes
of proteins that act in concert to translate signals of damaged
DNA into appropriate downstream responses. These comprise
(1) sensor proteins that recognize abnormally structured DNA
and initiate the signaling response, (2) transducers factors
that relay and amplify the damage signal on the surrounding
chromatin structure, and to (3) effector proteins that ultimately
lead to DNA damage repair (Bartek and Lukas, 2007; Harper and
Elledge, 2007). Thus, the DDR necessitates to be spatiotemporally
regulated (Ferrando-May et al.) because, if misused, it can wreak
havoc on DNA integrity.
The wide diversity of DNA injuries requires the activation
and cooperation of multiple and largely distinct DNA repair
mechanisms (Stracker et al.). Different DNA damages are
repaired by a sequence of catalytic events mediated by a plethora
of enzymes. Currently DNA repair pathways can be grouped in
different categories.
Nucleotide Excision Repair (NER), involves global genome
repair (GGR) and transcription-coupled repair (TCR),
recognizes and repair helix-distorting base lesions, such as
pyrimidine dimers, induced by UV light. A key aspect of NER
is the excision of the damaged DNA by specific endonuclease as
a short oligonucleotide, thus leading to the formation of single-
strand DNA, which is then acted by DNA polymerases before
ligation occurs. In Base Excision Repair (BER), a non-helix
distorting base modification, such as oxidation or alkylation,
is recognized by a DNA glycosylase that initiates the excision
of the modified base, thus leaving an apurinic or apirimidinic
site, from which nuclease, polymerase and ligase enzymes
can complete the repair. This pathway can operate via two
sub-pathways, short-path (SP-BER) or long-path (LP-BER),
based on the length of DNA re-synthesis. However, these two
pathways often converge and cause the formation of a SSB, which
is in turn sealed by a rapid process dependent on PARP [Poly
(ADP-ribose) polymerase]-mediated signaling. In mismatch
repair (MMR; Bak et al.; House et al.) incorrect polymerase
proofreading or ribonucleotide mis-incorporation in the DNA
chains occurring during DNA replication triggers the activation
of post-replicative DNA repair machinery, which degrades
mis-paired nucleotide of the newly synthesized strand, thus
assisting DNA polymerases with another chance to generate
an error-free copy of the template sequence (Jiricny, 2013).
Notably, lesions that block replication forks progression are
often by-passed by DNA damage tolerance (DTT) pathways.
Specialized translesion synthesis (TLS) DNA polymerases,
harboring a less stringent base-pair requirements than replicative
polymerases, restart stalled replication forks, thus preventing
their collapse and the consequent DSB formation, but at the
expense of a higher mutation rate; DTT pathway promotes the
completion rather than the accuracy of DNA replication. Repair
of DSBs relays on two major pathways: non-homologous end
joining (NHEJ; Lieber, 2008) and homologous recombination
(HR; San Filippo et al., 2008). Whereas, NHEJ can operate
throughout the cell cycle and is mostly used by post-mitotic
cells, HR requires the presence of an undamaged homologous
template, usually a sister chromatid, to mediate faithful repair
and is restricted to S- and G2-phase of actively replicating cells.
NHEJ promotes direct ligation of the two ends flanking the DSB
without the need of extensive DNA-end processing. However,
small insertions, deletions, and substitutions occurring at the
break site, make NHEJ an error-prone process. On the contrary,
HR mainly ensures an accurate repair of DSBs (Ferretti et al.;
Guirouilh-Barbat et al.) as it uses the homologous chromosome
as a template and it is often dedicated to fix breaks arising
from DNA replication stress. HR requires the generation of
ssDNA by DNA-end resection, which in turn invades the
undamaged template leading to the formation of branched
DNA structures. Therefore, DNA synthesis and recombination
intermediate dissolution complete the HR-mediated repair
process. Furthermore, DSBs which harbor a complementary
flanking sequence can also be repaired by alternative end-joining
(alt-NHEJ) also called microhomology-mediated end-joining
(MMEJ), whenmicrohomologies are present, or via single-strand
annealing (SSA) when longer repeats are present (Decottignies).
Although, MMEJ and SSA also rely on DNA-end resection
reminiscent of HR, they can lead to loss of intervening sequence
and thus are highly mutagenic (Kalan et al.; Guirouilh-Barbat
et al.; Blanco and Matos). Lastly, DNA interstrand crosslinks
(ICLs) represent the most serious kind of DNA lesions, as they
must be repaired through a complex mechanism involving NER,
TLS and HR, which are coordinated by the Fanconi Anemia (FA)
pathway.
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Spatiotemporal recruitment of DDR factors to sites of DNA
damage is promoted by sensor proteins, which activate specific
signaling cascades. It is becoming increasingly clear the biological
relevance of chromatin structure and epigenetic marks in the
DDR orchestration (Ferrando-May et al.; House et al.; Savic).
Efficient repair of DNA damage is complicated by the fact that
DNA is packaged into a condensed structure. Then, to facilitate
access of the DNA repair machinery to the lesion, transient
rearrangement of the chromatin has to occur. The nucleosome
is the fundamental unit of the chromatin and consists of
core particle, in which DNA is wrapped around a histone
octamer. Various histone posttranslational modifications (PTMs)
such as methylation, phosphorylation, acetylation, sumoylation,
and ubiquitination have been reported at different amino acid
residues of histones (Bartocci and Denchi; Bologna and Ferrari;
Ouyang et al.; Pinder et al.; Vaz et al.). Thus, the large number
of histone PTMs and the existence of diverse histone variants
can define specific chromatin configurations, which characterize
distinct stages in the DDR. Emerging evidences suggest that non-
coding RNAs (ncRNAs), as master regulators of chromatin, can
control the activation of DNA repair machinery by promoting
chromatin organization in different epigenetic states. On the
other side, ncRNAs, like microRNAs, may also act in the
biogenesis of core protein-coding components of DDR pathways
(Boucas et al.; Montecucco and Biamonti).
DDR regulates several physiological processes. DNA-repair
enzymes can introduce physiological DSBs to promote genetic
variability during meiosis in germ cells. DDR is indeed required
to promote genetic diversity via sexual reproduction by ensuring
the exchange of genetic information between homologous
chromosomes before meiosis (Carroll and Marangos). Moreover,
recombination processes are involved in the maturation of the
immune system, such as class-switch and V(D)J recombination
in B- and T-lymphocytes and play a critical role in the activation
of immune surveillance and in generating immune-receptor
diversity. Finally, DDR can determine whether a cell undergoes
apoptosis or terminal differentiation through senescence. In this
regard, markers of unrepaired DSBs accumulate with age at
telomeres (Arnoult and Karlseder, 2015; Feuerhahn et al., 2015),
which are nucleoprotein structures located at the end of our
chromosomes. Due to the inability of the replication machinery
to fully replicate chromosomal ends, telomeres shorten with each
cell division until they hardly retain telomeric DNA repeats
that are instead recognized as DSBs (Rosen; Henriksson and
Farnebo). Thus, under such context of chronic DDR activation at
telomeres, cells can enter into apoptosis or senescence (Fumagalli
and d’Adda di Fagagna, 2009).
Considering the biological relevance of DDR in diverse
physiological settings, “inherited” DDR defects predispose
cells to genome instability and consequent diseases, like
neurodegenerative disorders, immune deficiencies, infertility,
age-related pathologies, cardiovascular diseases, metabolic
syndromes, and cancer. The DDR is usually activated in
precancerous cells experiencing oncogene-induced replicative
stress and can be considered as an anticancer barrier that
protects against full cellular transformation. Otherwise, targeting
the replicative surge of cancer cells and their DDR/checkpoints
unbalance are the basis for classical radio- and chemo-therapy
and impairment of DNA repair pathways may represent a
window for therapeutic opportunity (Shahbazi et al.; Kotsinas
et al.). Cancer cells displaying specific DNA repair defects
become “addicted” to complementary, but often inaccurate
repair pathways in order to fuel their unscheduled expansion.
Recently, this effect has been successfully exploited for synthetic
lethality strategies, where small molecule inhibitors of these
alternative pathways lead to selective killing of cancer cells
harboring a specific genetic background, as in the case of PARP
inhibitor treatment of HR-deficient tumors. Although, DDR
components represent attractive targets for the development
of novel cancer-therapies, they can also provide a common
mechanism for cancer-therapy resistance. The development
of diagnostic procedures to identify DDR components altered
during oncogenesis might allow effective detection of pre-
malignant diseases and tailor DNA-damaging or DDR inhibitor
therapies for individual patients.
The relevance of the chemistry and biology of the DDR was
underscored by the Royal Swedish Academy of Sciences when it
awarded the Nobel Prize in Chemistry 2015 to three pioneering
scientists-Thomas Lindahl, Paul Modrich, and Aziz Sancar-for
having, independently of each-others, mapped and elucidated
the molecular basis of how cells repair their DNA. In the early
1970s, Thomas Lindhal was the first scientist to demonstrate
that the DNA decays at a slow but noticeable rate. This insight
led him to quest for repair enzymes discovering in this way the
BER pathway (Lindahl, 1974). At the same time, Aziz Sancar
investigated the effects of UV radiation on bacteria leading
him to uncover the NER pathway (Sancar and Rupp, 1983).
Paul Modrich instead focused his research on DNA replication
finding out how cell corrects errors during cell divisions: the
mismatch repair mechanism (Lahue et al., 1989). In the last two
decades, oncology research has been building on those findings
to develop the aforementioned conventional DNA-damaging
cancer treatment as well as newer targeted therapies by inhibiting
repair pathways.
This Research Topic is aimed at comprehensive investigations
of basic and novel mechanisms that underlie DNA damage
response in eukaryotes. All authors in this Research Topic have
provided their broad perspectives on distinct aspects of DDR and
their insightful thoughts will benefit the field and will provide
fertile ground for future investigations that we look forward to
seeing develop.
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